This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Defence Therapeutics Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Jeffrey Victor Leyton
Introduction
Jeffrey Victor Leyton is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of conjugated compounds that enhance cellular accumulation.
Latest Patents
Leyton holds a patent for "Conjugates enhancing total cellular accumulation." This patent describes a conjugated compound that includes cholic acid (ChAc) or a variant thereof. The ChAc is conjugated to a non-cell penetrating peptide that comprises a nuclear localization sequence (NLS) linked to a compound of interest. This innovative approach has the potential to improve the delivery of therapeutic agents within cells.
Career Highlights
Leyton is currently associated with Defence Therapeutics Inc., where he applies his expertise in biotechnology to advance the company's research and development efforts. His work focuses on creating novel solutions that can address various medical challenges.
Collaborations
Leyton collaborates with Simon Beaudoin, contributing to the innovative projects at Defence Therapeutics Inc. Their combined efforts aim to push the boundaries of current biotechnological applications.
Conclusion
Jeffrey Victor Leyton's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the area of cellular accumulation, highlight the importance of research and development in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile